CHROMOSOMAL MICROARRAY VS. WHOLE EXOME SEQUENCING

“๐“œ๐“ฒ๐“ฌ๐“ป๐“ธ๐“ช๐“ป๐“ป๐“ช๐”‚๐“ผ ๐“ฑ๐“ฎ๐“ต๐“น ๐“พ๐“ผ ๐“ฏ๐“ฒ๐“ท๐“ญ ๐“ถ๐“ฒ๐“ผ๐“ผ๐“ฒ๐“ท๐“ฐ ๐“ธ๐“ป ๐“ฎ๐”๐“ฝ๐“ป๐“ช ๐“ฌ๐“ฑ๐“ป๐“ธ๐“ถ๐“ธ๐“ผ๐“ธ๐“ถ๐“ช๐“ต ๐“น๐“ฒ๐“ฎ๐“ฌ๐“ฎ๐“ผ; ๐“ฆ๐“”๐“ข ๐“ฝ๐“ช๐“ด๐“ฎ๐“ผ ๐“พ๐“ผ ๐“ญ๐“ฎ๐“ฎ๐“น๐“ฎ๐“ป, ๐“ฒ๐“ท๐“ฝ๐“ธ ๐“ฝ๐“ฑ๐“ฎ ๐“ฌ๐“ธ๐“ญ๐“ฒ๐“ท๐“ฐ ๐“ป๐“ฎ๐“ฐ๐“ฒ๐“ธ๐“ท๐“ผ ๐”€๐“ฑ๐“ฎ๐“ป๐“ฎ ๐“ป๐“ช๐“ป๐“ฎ ๐“ฟ๐“ช๐“ป๐“ฒ๐“ช๐“ท๐“ฝ๐“ผ ๐“ฑ๐“ฒ๐“ญ๐“ฎ.” — Ellen Matloff

๐Ÿงฌ Chromosomal Microarray (CMA) and Whole Exome Sequencing (WES) are cornerstones of modern genomic diagnostics. Each offers unique insights: CMA identifies large-scale structural changes like copy number variations (CNVs), while WES investigates the exome; the protein-coding portion where most pathogenic mutations reside.

๐Ÿ”น CMA is a first-line tool for neurodevelopmental disorders, intellectual disability, and congenital anomalies. It scans for chromosomal imbalances missed by karyotyping, offering ~15–20% diagnostic yield in such cases. Its speed and cost-effectiveness make it a go-to for initial evaluations.

๐Ÿ”น WES, by contrast, dives into the exonic 1–2% of the genome that harbors ~85% of known disease-causing variants. WES is particularly useful in cases where CMA results are negative, especially when a monogenic disorder is suspected. It excels in detecting single nucleotide variants (SNVs), indels, and gene-disrupting mutations, but may miss structural rearrangements or low-level mosaicism.

๐Ÿ”น Comparison & Clinical Use:

CMA → Strong for CNVs; limited for point mutations.

WES → Strong for sequence variants; complex interpretation.

WES is best used after CMA in unresolved syndromic cases. The combined use improves yield, informing diagnosis, genetic counseling, and treatment.

          ➡️ WES presents challenges around incidental findings and variant uncertainty, requiring robust genetic counseling. CMA, though more targeted, may still identify risk alleles with familial or reproductive implications.

⚠️ In an Oystershell, CMA and WES are not rivals; they are complementary technologies. Together, they represent a genomic toolkit that supports precision diagnostics, enhances personalized medicine, and shapes the future of ethical, patient-centered care.

Abubakar Abubakar ✍️

• Serey-Gaut, Margaux et al.
The American Journal of Human Genetics, Volume 110, Issue 3, 499 - 515

• Rodriguez, Isabel et al.
The American Journal of Human Genetics, Volume 111, Issue 3, 544 - 561

#Genomics #GeneticTesting #WholeExomeSequencing #CMA #PrecisionMedicine #AJHG #ClinicalGenetics #RareDiseases #Bioethics #HumanGenetics #PersonalizedMedicine #SNV #CNV #WES #MolecularDiagnostics #GeneCounsel #ART #IVF

Comments

Post a Comment

Popular posts from this blog

UNDERSTANDING ACMG GUIDELINES & CLINICAL CLASSIFICATION OF GENETIC VARIANTS

Image
“๐“๐“ธ ๐“ผ๐“ฒ๐“ท๐“ฐ๐“ต๐“ฎ ๐“ต๐“ช๐“ซ๐“ธ๐“ป๐“ช๐“ฝ๐“ธ๐“ป๐”‚ ๐“ฑ๐“ช๐“ผ ๐“ฎ๐“ท๐“ธ๐“พ๐“ฐ๐“ฑ ๐“ญ๐“ช๐“ฝ๐“ช; ๐“ฌ๐“ธ๐“ต๐“ต๐“ช๐“ซ๐“ธ๐“ป๐“ช๐“ฝ๐“ฒ๐“ฟ๐“ฎ ๐“ฌ๐“พ๐“ป๐“ช๐“ฝ๐“ฒ๐“ธ๐“ท ๐“ฒ๐“ผ ๐“ฝ๐“ฑ๐“ฎ ๐“ฏ๐“พ๐“ฝ๐“พ๐“ป๐“ฎ ๐“ธ๐“ฏ ๐“ฐ๐“ฎ๐“ท๐“ธ๐“ถ๐“ฒ๐“ฌ ๐“ถ๐“ฎ๐“ญ๐“ฒ๐“ฌ๐“ฒ๐“ท๐“ฎ.” - Professor Heidi Rehm ๐Ÿงฌ Genomic medicine has moved from discovery to daily clinical decision-making. At the center of this shift are the 2015 standards from the American College of Medical Genetics & Genomics (ACMG), which established a structured framework for interpreting sequence variants.    ๐Ÿ”น Genetic variants influence disease risk, diagnosis, prognosis, & therapeutic strategy. Without standardized interpretation, clinical decisions become inconsistent. The ACMG/AMP framework addresses this by integrating multiple evidence streams into five categories: 1. Pathogenic (Class 5) 2. Likely Pathogenic (Class 4) 3. Variant of Uncertain Significance [VUS] (Class 3) 4. Likely Benign (Class 2) 5. Benign (Class 1) This tiered system reduces interpretive subjectivity & improves reproducibility...
Read more

BALANCED TRANSLOCATION

Image
"AN EXCHANGE CAN HAPPEN WITHOUT A GAIN OR LOSS, YET IT MAY PRODUCE SOME UNEXPECTED SIDE EFFECTS" ๐Ÿงฌ Balanced translocation is a type of chromosomal rearrangement where two segments of chromosomes are exchanged without any loss or gain of genetic material. This results in a rearrangement of genetic material within the chromosomes without any significant disruption. Balanced translocations typically involve the exchange of segments between non-homologous chromosomes, meaning that the segments are exchanged between different pairs of chromosomes.          ๐Ÿ”น Individuals with balanced translocations often do not display any outward physical signs or symptoms, as the total amount of genetic material remains the same. However, balanced translocations can have implications for health and reproduction. In some cases, balanced translocations can lead to infertility, recurrent miscarriages, or the potential for offspring to inherit unbalanced translocations, which do invo...
Read more

ERYTHEMA INFECTIOSUM

Image
"YOU MADE IT THROUGH PANDEMICS, BUT THERE'S STILL A FIFTH DISEASE" ๐Ÿงฌ Erythema Infectiosum, also known as Fifth Disease, is a viral infection caused by parvovirus B19. It is most common in children but can affect people of all ages. The characteristic symptom of erythema infectiosum is a distinctive rash on the cheeks giving a "slapped cheek" appearance, followed by a lacy rash on the trunk and limbs.            ๐Ÿ”ฌDiagnosis of erythema infectiosum is usually based on the characteristic rash and a history of exposure to the virus. In some cases, blood tests may be done to confirm the presence of parvovirus B19 antibodies.            ๐Ÿ’Š Treatment for erythema infectiosum is usually symptomatic, as the infection typically resolves on its own. Rest, fluids, and over-the-counter pain relievers may be recommended to alleviate symptoms.            ๐Ÿ’‰ Preventing the spread of erythema infectios...
Read more